Bouvel Investment Partners, LLC Adaptive Biotechnologies Corp Transaction History
Bouvel Investment Partners, LLC
- $254 Million
- Q4 2024
A detailed history of Bouvel Investment Partners, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Bouvel Investment Partners, LLC holds 43,805 shares of ADPT stock, worth $303,130. This represents 0.1% of its overall portfolio holdings.
Number of Shares
43,805
Previous 43,882
0.18%
Holding current value
$303,130
Previous $224,000
16.96%
% of portfolio
0.1%
Previous 0.09%
Shares
17 transactions
Others Institutions Holding ADPT
# of Institutions
204Shares Held
146MCall Options Held
68.8KPut Options Held
42.5K-
Viking Global Investors LP30MShares$208 Million0.59% of portfolio
-
Rubric Capital Management LP New York, NY14.4MShares$99.6 Million2.05% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$80.7 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.6MShares$80.3 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$73.6 Million0.0% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $989M
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...